Global Patent Index - EP 0969848 A1

EP 0969848 A1 2000-01-12 - USE OF DIADENOSINE POLYPHOSPHATES FOR REDUCING BLOOD PRESSURE

Title (en)

USE OF DIADENOSINE POLYPHOSPHATES FOR REDUCING BLOOD PRESSURE

Title (de)

VERWENDUNG VON DIADENOSIPOLYPHOSPHATE ZUR SENKUNG DES BLUTDRUCKES

Title (fr)

UTILISATION DE DIADENOSINE POLYPHOSPHATES POUR REDUIRE LA PRESSION SANGUINE

Publication

EP 0969848 A1 (EN)

Application

EP 98901777 A

Priority

  • US 9800546 W
  • US 3581997 P

Abstract (en)

[origin: WO9830222A1] A process for reducing blood pressure is disclosed. The process includes the step of administering to a patient one or more adenylated dinucleotides. Particular examples of adenylated dinucleotides that may be used in the process of the present invention include diadenosine triphosphate, diadenosine tetraphosphate, diadenosine pentaphosphate, and diadenosine hexaphosphate. By reducing blood pressure, the composition of the present invention can be used to treat a patient during hypertensive emergencies, can be used to reduce bleeding, and can be used to treat acute congestive heart failure.

IPC 1-7 (main, further and additional classification)

A61K 31/70

IPC 8 full level (invention and additional information)

A61K 31/70 (2006.01)

CPC (invention and additional information)

A61K 31/7076 (2013.01)

Citation (search report)

See references of WO 9830222A1

Designated contracting state (EPC)

AT BE CH DE DK ES FR GB IT LI PT SE

EPO simple patent family

WO 9830222 A1 19980716; AU 5821898 A 19980803; CA 2277479 A1 19980716; EP 0969848 A1 20000112

INPADOC legal status


2002-01-02 [18D] DEEMED TO BE WITHDRAWN

- Effective date: 20010618

2001-03-21 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20010206

2000-01-12 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 19990713

2000-01-12 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A1

- Designated State(s): AT BE CH DE DK ES FR GB IT LI PT SE